Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Baricitinib is effective and safe for treating severe alopecia areata.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

3% topical minoxidil effectively treats extensive alopecia areata with few side effects.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.